Celest Therapeutics (Shanghai) Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Celest Therapeutics (Shanghai) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| An Early Clinical Study to Evaluate the Safety and Efficacy of CLDN18.2 CAR T Cell Injection in Subjects With CLDN18.2-Positive Advanced Malignant Solid Tumors (NCT07680257) | Celest Therapeutics (Shanghai) Co., Ltd. | 2025-12-27 |
Track Celest Therapeutics (Shanghai) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.